Aspargo Labs Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
IPO
- (Cancelled)
Aspargo Labs General Information
Description
Aspargo Labs Inc is a commercial stage, specialty pharmaceutical and med-tech company focused on designing, developing and marketing oral liquid suspension formulations of oral solid dose Rx and OTC medications for administration in personalized, digitally connected, electronic drug delivery devices and accompanying mobile apps. Its first commercial product, Sildenafil Oral Suspension is a proprietary oral spray liquid suspension formulation of sildenafil citrate, the active ingredient in VIAGRA, indicated for the treatment of erectile dysfunction (ED).
Contact Information
Website
www.aspargolabs.comCorporate Office
- 17 State Street
- Suite 3220
- New York, NY 10004
- United States
Corporate Office
- 17 State Street
- Suite 3220
- New York, NY 10004
- United States
Aspargo Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. IPO | 10-Jan-2025 | Cancelled | Generating Revenue | |||
| 3. Early Stage VC | 05-Dec-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 28-Mar-2022 | $1.53M | $9.4M | Completed | Generating Revenue | |
| 1. Seed Round | 15-Oct-2020 | $7.9M | $7.9M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aspargo Labs Comparisons
Industry
Financing
Details
Aspargo Labs Competitors (2)
One of Aspargo Labs’s 2 competitors is Merck, a Corporation company based in Darmstadt, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merck | Corporation | Darmstadt, Germany | ||||
| Pfizer | Corporation | New York, NY |
Aspargo Labs Patents
Aspargo Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12558700-B1 | Pump dispenser having a safety lock pump head | Active | 12-Mar-2025 | ||
| US-20260273561-A1 | Pump dispenser having a safety lock pump head | Pending | 12-Mar-2025 | ||
| WO-2026192600-A1 | Pump dispenser having a safety lock pump head | Pending | 12-Mar-2025 | ||
| WO-2026142738-A1 | Medication cartridge | Pending | 23-Dec-2024 | ||
| US-20260115749-A1 | Pump dispenser having a safety lock cap | Pending | 24-Sep-2024 | B05B11/1059 |
Aspargo Labs Signals
Aspargo Labs Investments (1)
Aspargo Labs’s most recent deal was a Corporate Asset Purchase with Farmalider (International Rights to Sildenafil Spray in Madrid, Spain). The deal was made on 29-Sep-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Farmalider (International Rights to Sildenafil Spray in Madrid, Spain) | 29-Sep-2020 | Corporate Asset Purchase | Buildings and Property |
Aspargo Labs FAQs
-
When was Aspargo Labs founded?
Aspargo Labs was founded in 2019.
-
Where is Aspargo Labs headquartered?
Aspargo Labs is headquartered in New York, NY.
-
What is the size of Aspargo Labs?
Aspargo Labs has 36 total employees.
-
What industry is Aspargo Labs in?
Aspargo Labs’s primary industry is Biotechnology.
-
Is Aspargo Labs a private or public company?
Aspargo Labs is a Private company.
-
What is Aspargo Labs’s current revenue?
The current revenue for Aspargo Labs is .
-
How much funding has Aspargo Labs raised over time?
Aspargo Labs has raised $10.4M.
-
Who are Aspargo Labs’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process